Table 3.
Gender | Age | CK |
Anti-NT5c1A titer (MFU)* |
Dysphagia (Y/N) |
Severity (1 = Mild, 2 = Moderate, 3 = Severe) |
---|---|---|---|---|---|
F | 54 | 732 | 276 | Y | 2 |
M | 83 | 812 | 576 | Y | 2 |
F | 82 | 163 | 1457 | Y | 3 |
M | 79 | 170 | 3815 | Y | 1 |
M | 79 | 533 | 3042 | Y | 2 |
F | 76 | 792 | 400 | Y | 3 |
M | 75 | 419 | 6034 | Y | 3 |
M | 75 | 219 | 869 | Y | 2 |
F | 73 | 486 | 803 | Y | 2 |
F | 73 | 250 | 23911 | Y | 2 |
M | 71 | 153 | 387 | Y | 1.5 |
F | 71 | 175 | 1312 | Y | 2.5 |
M | 70 | 490 | 278 | Y | 2 |
F | 70 | N/A | 246 | Y | 1 |
F | 69 | 476 | 1594 | Y | 1.5 |
M | 67 | 669 | 740 | Y | 2.5 |
M | 65 | 329 | 1683 | Y | 2 |
F | 62 | 796 | 336 | Y | 2 |
M | 60 | N/A | 592 | Y | 3 |
F | 57 | 1265 | 26623 | Y | 2 |
M | 56 | 363 | 17748 | Y | 2.5 |
F | 56 | 710 | 1903 | Y | 3 |
M | 54 | 261 | 112 | Y | 1 |
M | 86 | 355 | 151 | N | 2 |
M | 81 | 110 | 331 | N | 2 |
M | 76 | 703 | 441 | N | 1 |
M | 76 | 279 | 184 | N | 1 |
F | 75 | 232 | 157 | N | 1.5 |
M | 74 | 391 | 99.5 | N | 2 |
F | 74 | 901 | 12370 | N | 1 |
F | 73 | 215 | 649.5 | N | 1.5 |
M | 72 | 305 | 518 | N | 1.5 |
M | 72 | 502 | 12706 | N | 2 |
M | 69 | 469 | 256 | N | 2 |
M | 67 | 624 | 283 | N | 2 |
M | 67 | 500 | 164 | N | 1.5 |
F | 67 | 310 | 157 | N | 2 |
M | 60 | N/A | 477 | N | 2 |
M | 58 | 481 | 4960 | N | 2 |
M | 55 | 367 | 1039 | N | 2 |
M | 54 | 596 | 276 | N | 1.5 |
F | 54 | 617 | 1023 | N | 3 |
M | 53 | 204 | 21563 | N | 3 |
37.2% female | Median: 70.0 IQR 60.0,75.0 |
Median: 444.0 IQR 252.8, 622.3 |
Median: 592.0 IQR 276.0, 1903.0 |
53% had dysphagia | Median: 2.0 IQR 1.5, 2.1 |
Shaded cells indicate positive results of >600 MFU (cutoff). F, female; IQR, interquartile range; M, male; MFU, median fluorescence units; NA, not available; N, no; Y, yes.